The role of neoadjuvant chemotherapy in ovarian cancer patients with extensive tumor burden

Journal of Gynecologic Oncology

Volumn 22, Issue 4, 2011, Pages 299-

  Kang, Sokbom ^a  

^a National Cancer Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT CHEMOTHERAPY; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; EDITORIAL; OVARY CANCER; OVERALL SURVIVAL; PROGRESSION FREE SURVIVAL;

EID: 84857661830     PISSN: 20050380     EISSN: 20050399     Source Type: Journal    
DOI: 10.3802/jgo.2011.22.4.299     Document Type: Editorial

References (2)

1. Menczer J, Usviatzov I, Ben-Shem E, Golan A, Levy T. Neoadjuvant chemotherapy in ovarian, primary peritoneal and tubal carcinoma: can imaging results prior to interval debulking predict survival? J Gynecol Oncol 2010;22:183-7.
2. Nelson BE, Rosenfield AT, Schwartz PE. Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma. J Clin Oncol 1993;11:166-72.